Skip to main content
. 2017 Apr 9;8(6):1103–1112. doi: 10.7150/jca.17688

Figure 7.

Figure 7

The MTT pictures of proapoptosis effects of tuberostemonine combined with adriamycin and Adriamycin alone. A: K562/ADR + 200μg/mL + Adriamycin; B: K562/ADR + 350μg/mL + Adriamycin; C: K562/ADR + 500μg/mL + Adriamycin; D: K562/ADR + Adriamycin.